Jabr Fadi I, Yu Ling
J Med Liban. 2016 Jan-Mar;64(1):40-2. doi: 10.12816/0023831.
Thrombotic microangiopathy is characterized by endothelial changes and microvascular stenosis. Several entities such as pregnancy, infection, connective tissue diseases, and drugs are associated with secondary thrombotic microangiopathy. Recently, new reformulation of Opana ER had been associated with thrombotic microangiopathy when injected intravenously. Here, we report the case of a 37-year-old man who developed renal failure and hemolytic anemia secondary to Opana ER intravenous abuse. Renal biopsy pathology was consistent with thrombotic microangiopathy likely caused by Opana ER intravenous abuse.
血栓性微血管病的特征是内皮细胞改变和微血管狭窄。妊娠、感染、结缔组织病和药物等多种因素与继发性血栓性微血管病有关。最近,奥施康定控释片(Opana ER)重新配方后静脉注射与血栓性微血管病有关。在此,我们报告一例37岁男性病例,该患者因静脉滥用奥施康定控释片继发肾衰竭和溶血性贫血。肾活检病理与可能由静脉滥用奥施康定控释片引起的血栓性微血管病相符。